-
GAIL (India) Ltd rises for third consecutive session
GAIL (India) Ltd is quoting at Rs 131.6, up 1.46% on the day as on 12:49 IST on the NSE. The stock is up 10.68% in last one year as compared to a 23.82% spurt in NIFTY and a 14.99% spurt in the Nifty
Capital MarketFebruary 3, 2021/2:30 PM IST -
UTI Arbitrage Fund announces dividend
UTI Mutual Fund has announced February 8 as the record date for declaration of dividend under Dividend Option-Regular Plan and Dividend Option-Direct Plan of UTI Arbitrage Fund.
Capital MarketFebruary 3, 2021/2:20 PM IST -
India’s budget shot in the arm for economy, fiscal consolidation takes a back seat: S&P
Budget's emphasis on capital expenditure marks a noteworthy shift, and higher investment in India's physical infrastructure should help to raise investment potential and competitiveness in the economy over time.
PTIFebruary 3, 2021/2:17 PM IST -
Surya Roshni rises after order win
Surya Roshni gained 1.18% to Rs 341.85 after the company said it received an order worth Rs 85.53 crore for supplying API coated grade pipes to Bharat Gas Resources.
Capital MarketFebruary 3, 2021/1:03 PM IST -
Maruti Suzuki slips on profit booking
Maruti Suzuki India fell 1.40% to Rs 7548.45 as the counter witnessed some bit of profit taking.
Capital MarketFebruary 3, 2021/1:01 PM IST -
Budget 2021 is a big step towards Aatmanirbhar Bharat
The first paperless budget presented by the Union Finance Minister, Nirmala Sitharaman is a step towards making India, truly self-reliant.
Vineet AgarwalFebruary 3, 2021/12:37 PM IST -
Brookfield India Real Estate Trust IPO opens: Should you subscribe?
Initial public offering (IPO) by the global investment firm Brookfield India Real Estate Trust (REITs) hit the capital market on Wednesday to raise up to Rs 3,800 crore.
Rahul OberoiFebruary 3, 2021/12:08 PM IST -
BSE Realty index flat; DLF, Phoenix Mills shares down up to 1.58%
DLF Ltd has added 18.6% over last one month compared to 6.48% gain in S&P BSE Realty Index index and 3.7% rise in the SENSEX
Capital MarketFebruary 3, 2021/11:08 AM IST -
Glenmark Pharma gains after USFDA approves
Glenmark Pharmaceuticals rose 1.85% to Rs 496.35 after the company said it received final approval from the US drug regulator for topiramate extended-release capsules.
Capital MarketFebruary 3, 2021/11:03 AM IST
